75 related articles for article (PubMed ID: 3217827)
1. Development of the second generation Japanese encephalitis (JE) vaccine.
Igarashi A
Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):493-500. PubMed ID: 3217827
[TBL] [Abstract][Full Text] [Related]
2. Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine.
Konishi E; Yamaoka M; Kurane I; Mason PW
Virology; 2000 Mar; 268(1):49-55. PubMed ID: 10683326
[TBL] [Abstract][Full Text] [Related]
3. Studies in the development of Japanese encephalitis vaccine: expression of virus envelope glycoprotein V3 (E) gene in yeast.
Fujita H; Sumiyoshi H; Mori C; Manabe S; Takagi M; Yoshida I; Morita K; Fuke I; Fukai K; Igarashi A
Bull World Health Organ; 1987; 65(3):303-8. PubMed ID: 2822272
[TBL] [Abstract][Full Text] [Related]
4. Generation and characterization of a mammalian cell line continuously expressing Japanese encephalitis virus subviral particles.
Konishi E; Fujii A; Mason PW
J Virol; 2001 Mar; 75(5):2204-12. PubMed ID: 11160724
[TBL] [Abstract][Full Text] [Related]
5. Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice.
Li Y; Ye J; Cao S; Xiao S; Zhao Q; Liu X; Jin M; Chen H
J Gene Med; 2009 Feb; 11(2):150-9. PubMed ID: 19040206
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
[TBL] [Abstract][Full Text] [Related]
7. Development of a simple fed-batch process for the high-yield production of recombinant Japanese encephalitis virus protein.
Tripathi NK; Shukla J; Biswal KC; Lakshmana Rao PV
Appl Microbiol Biotechnol; 2010 May; 86(6):1795-803. PubMed ID: 20177885
[TBL] [Abstract][Full Text] [Related]
8. Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice.
Li Y; Ye J; Cao S; Xiao S; Zhao Q; Liu X; Jin M; Chen H
J Gene Med; 2009 Jan; 11(1):57-65. PubMed ID: 19006097
[TBL] [Abstract][Full Text] [Related]
9. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.
Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L
Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388
[TBL] [Abstract][Full Text] [Related]
10. Japanese encephalitis subunit vaccine composed of virus-like envelope antigen particles purified from serum-free medium of a high-producer J12#26 cell clone.
Mutoh E; Ishikawa T; Takamizawa A; Kurata T; Sata T; Kojima A
Vaccine; 2004 Jun; 22(20):2599-608. PubMed ID: 15193385
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of peptides cleaved by cyanogen bromide from Japanese encephalitis virus envelope glycoprotein E.
Srivastava AK; Morita K; Igarashi A
Acta Virol; 1990 May; 34(3):228-38. PubMed ID: 1980396
[TBL] [Abstract][Full Text] [Related]
12. Selection of immunodominant fragments from envelope gene for vaccine against Japanese encephalitis virus in DNA priming-protein boosting protocols.
Chen CT; Yi YC; Chiang SC; Liu KC; Lin YL; Lee ST
Microb Pathog; 2005; 38(2-3):53-62. PubMed ID: 15748807
[TBL] [Abstract][Full Text] [Related]
13. Enzyme-linked immunosorbent assay for detection of serum antibody in children vaccinated with Japanese encephalitis vaccine.
Okamoto Y; Okuno Y; Yamada A; Baba K; Yabuuchi H
Biken J; 1986 Dec; 29(3-4):57-62. PubMed ID: 3619879
[TBL] [Abstract][Full Text] [Related]
14. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
[TBL] [Abstract][Full Text] [Related]
15. Japanese encephalitis vaccines: moving away from the mouse brain.
Zanin MP; Webster DE; Martin JL; Wesselingh SL
Expert Rev Vaccines; 2003 Jun; 2(3):407-16. PubMed ID: 12903806
[TBL] [Abstract][Full Text] [Related]
16. Potency testing of inactivated tissue culture vaccine against Japanese encephalitis using antigen capture ELISA.
Joshi AM; Walimbe AM; Banerjee K
Acta Virol; 1997 Jun; 41(3):157-9. PubMed ID: 9385404
[TBL] [Abstract][Full Text] [Related]
17. [A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].
Zhou B; Jia L; Xu X
Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Feb; 20(1):38-41. PubMed ID: 10682513
[TBL] [Abstract][Full Text] [Related]
18. Poxvirus-based Japanese encephalitis vaccine candidates induce JE virus-specific CD8+ cytotoxic T lymphocytes in mice.
Konishi E; Kurane I; Mason PW; Shope RE; Ennis FA
Virology; 1997 Jan; 227(2):353-60. PubMed ID: 9018134
[TBL] [Abstract][Full Text] [Related]
19. Enzyme-linked immunosorbent assay using recombinant antigens for serodiagnosis of Japanese encephalitis.
Konishi E; Mason PW; Shope RE
J Med Virol; 1996 Jan; 48(1):76-9. PubMed ID: 8825714
[TBL] [Abstract][Full Text] [Related]
20. Construction and evaluation of a chimeric pseudoinfectious virus vaccine to prevent Japanese encephalitis.
Ishikawa T; Widman DG; Bourne N; Konishi E; Mason PW
Vaccine; 2008 May; 26(22):2772-81. PubMed ID: 18433947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
